News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Genzyme Corporation’s Sale of Testing Unit May Force Sanofi-Aventis (France) to Increase Takeover Offer
September 14, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Genzyme Corp., a takeover target of Sanofi-Aventis SA, agreed to sell its diagnostic testing unit to Laboratory Corp. of America Holdings for $925 million in cash.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Sanofi (France)
MORE ON THIS TOPIC
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
November 14, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
November 14, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer Closes Metsera Deal, Officially Ending Bidding War Drama
November 13, 2025
·
1 min read
·
Annalee Armstrong
China
Recently Launched Third Arc Turns to China for Cancer T Cell Engagers
November 13, 2025
·
2 min read
·
Tristan Manalac